Handelsbanken Fonder’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-7,000
| Closed | -$2.22M | – | 1576 |
|
2023
Q4 | $2.22M | Buy |
7,000
+1,300
| +23% | +$412K | 0.01% | 537 |
|
2023
Q3 | $964K | Buy |
5,700
+600
| +12% | +$101K | 0.01% | 742 |
|
2023
Q2 | $1.11M | Buy |
5,100
+1,300
| +34% | +$282K | 0.01% | 706 |
|
2023
Q1 | $690K | Hold |
3,800
| – | – | ﹤0.01% | 850 |
|
2022
Q4 | $747K | Hold |
3,800
| – | – | ﹤0.01% | 751 |
|
2022
Q3 | $855K | Buy |
3,800
+400
| +12% | +$90K | 0.01% | 711 |
|
2022
Q2 | $430K | Hold |
3,400
| – | – | ﹤0.01% | 1112 |
|
2022
Q1 | $431K | Sell |
3,400
-1,900
| -36% | -$241K | ﹤0.01% | 1310 |
|
2021
Q4 | $694K | Sell |
5,300
-300
| -5% | -$39.3K | ﹤0.01% | 1127 |
|
2021
Q3 | $685K | Buy |
5,600
+1,300
| +30% | +$159K | ﹤0.01% | 1131 |
|
2021
Q2 | $490K | Buy |
4,300
+600
| +16% | +$68.4K | ﹤0.01% | 1397 |
|
2021
Q1 | $445K | Hold |
3,700
| – | – | ﹤0.01% | 1259 |
|
2020
Q4 | $376K | Buy |
+3,700
| New | +$376K | ﹤0.01% | 1308 |
|
2020
Q3 | – | Sell |
-2,200
| Closed | -$245K | – | 1473 |
|
2020
Q2 | $245K | Buy |
+2,200
| New | +$245K | ﹤0.01% | 1306 |
|